Results
1
-
3
of
3
Antineoplastics
,
Reactions Weekly
[DOI: 10.1007/s40278-017-38316-7]
Enasidenib: First Global Approval
,
Drugs
[DOI: 10.1007/s40265-017-0813-2]
Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
,
Current Hematologic Malignancy Reports
[DOI: 10.1007/s11899-017-0418-6]